Prospects of plasmapheresis for patients with severe COVID-19
On February 11, 2020, the World Health Organization officially named the infection caused by the new coronavirus “Coronavirus disease 2019” (COVID-19). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) officially named the infectious matter “severe acute respiratory syn...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-09-01
|
| Series: | European Journal of Translational Myology |
| Subjects: | |
| Online Access: | https://pagepressjournals.org/index.php/bam/article/view/9165 |
| _version_ | 1818749905870520320 |
|---|---|
| author | Ilmira R. Gilmutdinova Maksim Yu. Yakovlev Petr S. Eremin Anatoliy D. Fesun |
| author_facet | Ilmira R. Gilmutdinova Maksim Yu. Yakovlev Petr S. Eremin Anatoliy D. Fesun |
| author_sort | Ilmira R. Gilmutdinova |
| collection | DOAJ |
| description | On February 11, 2020, the World Health Organization officially named the infection caused by the new coronavirus “Coronavirus disease 2019” (COVID-19). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) officially named the infectious matter “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2). Emergence of severe complications with new coronavirus disease is due to the development of hypercytokinaemia, also known as “cytokine storm”. These complications comprise acute respiratory distress syndrome (ARDS), respiratory failure and death. Emerging data point to the logic of using extracorporeal haemocorrection to normalise cytokine levels and reduce the severity of organ disorders. The analysis of the literature indicates that to date, a certain positive experience has been accumulated in the world in the application of extracorporeal methods in clinical practice in patients with COVID-19. |
| first_indexed | 2024-12-18T04:11:13Z |
| format | Article |
| id | doaj.art-9fed0bf9771248dcb2c2097ba6c437d3 |
| institution | Directory Open Access Journal |
| issn | 2037-7452 2037-7460 |
| language | English |
| last_indexed | 2024-12-18T04:11:13Z |
| publishDate | 2020-09-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | European Journal of Translational Myology |
| spelling | doaj.art-9fed0bf9771248dcb2c2097ba6c437d32022-12-21T21:21:29ZengPAGEPress PublicationsEuropean Journal of Translational Myology2037-74522037-74602020-09-0110.4081/ejtm.0.9165Prospects of plasmapheresis for patients with severe COVID-19Ilmira R. Gilmutdinova0Maksim Yu. Yakovlev1Petr S. Eremin2Anatoliy D. Fesun3Federal State Budgetary Institution “National Medical Research Centre for Rehabilitation and Balneology” of the Ministry of Health of Russia, MoscowFederal State Budgetary Institution “National Medical Research Centre for Rehabilitation and Balneology” of the Ministry of Health of Russia, MoscowFederal State Budgetary Institution “National Medical Research Centre for Rehabilitation and Balneology” of the Ministry of Health of Russia, MoscowFederal State Budgetary Institution “National Medical Research Centre for Rehabilitation and Balneology” of the Ministry of Health of Russia, MoscowOn February 11, 2020, the World Health Organization officially named the infection caused by the new coronavirus “Coronavirus disease 2019” (COVID-19). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) officially named the infectious matter “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2). Emergence of severe complications with new coronavirus disease is due to the development of hypercytokinaemia, also known as “cytokine storm”. These complications comprise acute respiratory distress syndrome (ARDS), respiratory failure and death. Emerging data point to the logic of using extracorporeal haemocorrection to normalise cytokine levels and reduce the severity of organ disorders. The analysis of the literature indicates that to date, a certain positive experience has been accumulated in the world in the application of extracorporeal methods in clinical practice in patients with COVID-19.https://pagepressjournals.org/index.php/bam/article/view/9165plasmapheresisextracorporeal haemocorrectionCOVID-19coronavirus |
| spellingShingle | Ilmira R. Gilmutdinova Maksim Yu. Yakovlev Petr S. Eremin Anatoliy D. Fesun Prospects of plasmapheresis for patients with severe COVID-19 European Journal of Translational Myology plasmapheresis extracorporeal haemocorrection COVID-19 coronavirus |
| title | Prospects of plasmapheresis for patients with severe COVID-19 |
| title_full | Prospects of plasmapheresis for patients with severe COVID-19 |
| title_fullStr | Prospects of plasmapheresis for patients with severe COVID-19 |
| title_full_unstemmed | Prospects of plasmapheresis for patients with severe COVID-19 |
| title_short | Prospects of plasmapheresis for patients with severe COVID-19 |
| title_sort | prospects of plasmapheresis for patients with severe covid 19 |
| topic | plasmapheresis extracorporeal haemocorrection COVID-19 coronavirus |
| url | https://pagepressjournals.org/index.php/bam/article/view/9165 |
| work_keys_str_mv | AT ilmirargilmutdinova prospectsofplasmapheresisforpatientswithseverecovid19 AT maksimyuyakovlev prospectsofplasmapheresisforpatientswithseverecovid19 AT petrseremin prospectsofplasmapheresisforpatientswithseverecovid19 AT anatoliydfesun prospectsofplasmapheresisforpatientswithseverecovid19 |